/Investor DB

Ulu Ventures — 2022 Investments

10 investments dated 2022 · listed companies and verified rows first · show all

Kognizkogniz.comSeed · Aug 2022 · $10M

Kogniz is a digital platform and content hub that covers technology trends, innovation, and emerging platforms including mobile apps, VR, and PaaS solutions.

Advanced ManufacturingDeveloper ToolsMedia & EntertainmentBerkeley, US

Daniel Putterman(Executive Officer, Director)Jed Putterman(Executive Officer, Director)Tom Chavez(Director)David Ron(Executive Officer, Director)Gregorio Schneider(Director)

BoardStephen Plume(Director)

Board seatClint Korver· per SEC Form D

Co-investorsK20 FundWestern Technology Investmentsuper{set}

Datacydatacy.comin𝕏Seed · May 2022 · $6M

Datacy measures and optimizes the consumer journey across discovery, validation, search, comparison, and purchase by tracking behavior signals across AI, social, search, commerce, and retail channels.

ConsumerMarketing TechSan Jose, US

Paroma Indilo(Executive Officer, Director)

BoardDana Wright(Director)in

Co-investorsAuxxoData TechExcelestar VenturesGraham Walker VentureHeartfelt CapitalHEARTFELT_+6 more

Finalisfinalis.cominJul 2022 · $10.7M

Finalis operates a platform connecting institutional investors to pre-vetted private market deal opportunities sourced from a network of M&A bankers and placement agents.

B2B MarketplacesEnterprise SoftwareFintechSaaSUnited States, US

Federico Baradello(Founder & CEO)inAlejandro Sueldo(Chief Operating Officer and General Counsel)in

Co-investorsAltari VenturesBanyan VenturesChaac VenturesEnabling FutureEverywhere VenturesGaingels+4 more

FreeWillfreewill.cominFeb 2022

FreeWill provides a free online platform for creating legally valid estate plans and charitable giving tools.

FintechImpact & Social GoodLegalTechNew York, US

JennyPatrick William Schmitt(Executive Officer, Director)Jennifer Xia Spradling(Executive Officer, Director)inJennifer Xia(Cofounder)inAndrew B Nick(Executive Officer)Jenny Xia Spradling(Founder)

Co-investorsBain Capital Double Impact Fund LPDorm RoomHearstLabICONIQPear VCPurpose Built Ventures+4 more

Hey Janeheyjane.comin𝕏Oct 2022 · $6.1M

Hey Jane is a US virtual clinic that connects patients with clinicians via telehealth for abortion care and other reproductive and sexual health services.

Digital HealthFemTechHealthtechNew York City, US

Kiki Freedman(Founder)inAmy Potter(Chief Medical Officer)inGaby Izarra(Founder)Kate Shaw(Founder)

Co-investors37 AngelsAlumni VenturesAmboy Street VenturesBlue Trail PartnersDorm RoomFeldsmith Capital+9 more

Lead Salesleadsales.ioin𝕏Pre-Seed · Oct 2022 · $400K

Leadsales is a CRM platform that centralizes customer conversations from WhatsApp, Facebook, and Instagram in a single interface, enabling sales teams to manage leads, automate follow-ups, and organize sales processes.

Marketing TechSaaSSales TechSantiago de Querétaro, MX

Roby Peñacastro(Founder)inDavid Villa(Founder)in

Co-investorsAltered VenturesBreakaway Partners OÜGaingelsLatitud VenturesRegion CuatroStartX+1 more

Pastelpastel.africainAug 2022 · $5.5M

Pastel is an agentic AI platform that automates banking operations workflows including customer due diligence, fraud detection, AML screening, and executive insights for regulated banks.

AI & Machine LearningEnterprise SoftwareFintech

Abuzar Royesh(Founder)Izunna Okonkwo(Founder)Olamide Oladeji(Founder)

Co-investorsPlug and Play VenturesSoma CapitalStartXThe MBA FundDFS LabGlobal Founders Capital+2 more

Prixzprixz.cominApr 2022

Prixz is an online pharmacy operating across Mexico that delivers medications, vitamins, dermocosmetics, and health products to customers nationwide.

Digital HealthE-commerceHealthtechMexico City, MX

Co-investorsEndurance28SV Latam Capital

Prixzprixz.com.coApr 2022

The page presents AO88, an online betting and gambling platform offering sports betting, live casino games, slot games, fish shooting games, and lottery.

ConsumerGaming

Co-investorsSV Latam Capital

VerImmuneverimmune.comin𝕏Jul 2022 · $2.5M

VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity.

BiotechHealthtechMedical DevicesBethesda, US

JOSHUA WANG(Executive Officer, Director, Promoter)inJOHN TROYER(Executive Officer)

BoardCYNTHIA POH(Director)KEVIN KOH RONGSHENG(Director)HAOLIN SUNG(Director)inCHE HSU(Director)in

Co-investorsGaingelsMana VenturesMaryland TEDCONuFund Venture GroupSymbiotic Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.